- Home
- LIVN vs SGRY Comparison
LIVN vs SGRY Comparison
Compare LIVN & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- SGRY
- Stock Information
- Founded
- LIVN 1987
- SGRY 2004
- Country
- LIVN United Kingdom
- SGRY United States
- Employees
- LIVN N/A
- SGRY N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SGRY Hospital/Nursing Management
- Sector
- LIVN Health Care
- SGRY Health Care
- Exchange
- LIVN Nasdaq
- SGRY Nasdaq
- Market Cap
- LIVN 2.9B
- SGRY 2.8B
- IPO Year
- LIVN 1993
- SGRY 2015
- Fundamental
- Price
- LIVN $57.65
- SGRY $15.64
- Analyst Decision
- LIVN Strong Buy
- SGRY Buy
- Analyst Count
- LIVN 7
- SGRY 7
- Target Price
- LIVN $60.00
- SGRY $29.86
- AVG Volume (30 Days)
- LIVN 599.4K
- SGRY 1.9M
- Earning Date
- LIVN 11-05-2025
- SGRY 11-10-2025
- Dividend Yield
- LIVN N/A
- SGRY N/A
- EPS Growth
- LIVN N/A
- SGRY N/A
- EPS
- LIVN N/A
- SGRY N/A
- Revenue
- LIVN $1,348,962,000.00
- SGRY $3,288,100,000.00
- Revenue This Year
- LIVN $10.10
- SGRY $9.78
- Revenue Next Year
- LIVN $7.90
- SGRY $9.59
- P/E Ratio
- LIVN N/A
- SGRY N/A
- Revenue Growth
- LIVN 8.63
- SGRY 10.14
- 52 Week Low
- LIVN $32.48
- SGRY $15.40
- 52 Week High
- LIVN $58.91
- SGRY $30.11
- Technical
- Relative Strength Index (RSI)
- LIVN 62.26
- SGRY 19.31
- Support Level
- LIVN $48.82
- SGRY $21.19
- Resistance Level
- LIVN $51.97
- SGRY $22.29
- Average True Range (ATR)
- LIVN 1.86
- SGRY 0.87
- MACD
- LIVN 0.14
- SGRY -0.73
- Stochastic Oscillator
- LIVN 85.96
- SGRY 4.98
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.